https://danyelza.com/
Relapsed/Refractory High-risk Neuroblastoma | DANYELZA® (naxitamab-gqgk)
high riskrelapsedrefractoryneuroblastomanaxitamab
https://adisinsight.springer.com/drugsafety/803927323?error=cookies_not_supported&code=260f06df-aa19-4269-8a53-2ef0c652c5df
Naxitamab/Lorlatinib - AdisInsight
A 12-year-old patient with refractory high-risk stage M neuroblastoma and persistent bone and bone marrow involvement experienced hypotension, abdominal pain
naxitamablorlatinibadisinsight